Australian vaccine set for overseas test

The effectiveness of a University of Queensland vaccine for coronavirus is about to be tested in a biosecurity facility in the Netherlands.

The vaccine will be used on live coronavirus for the first time to determine how effectively it induces protection against infection.

UQ's vaccine program co-leader Dr Keith Chappell said the trial will establish a critical package of data ahead of human clinical trials later this year. Clinical studies will be conducted by Viroclinics Xplore which offers a myriad of preclinical tests including toxicology of drugs, antibodies, and antivirals targeting viral infectious diseases.

 

UQ created COVID-19 in its laboratory and then set about designing a vaccine to combat the virus.

The vaccine locks the "spike" protein into a shape which allows the immune system to be able to recognise and neutralise it.

UQ's Professor Trent Munro said beginning a large multi-arm study at Viroclinics Xplore was critical, before human testing, because it would establish a more comprehensive understanding of how the vaccine performs.

Originally published as UQ coronavirus vaccine set for overseas test



Early Ipswich Cup tips: Excellent track but rug up

Premium Content Early Ipswich Cup tips: Excellent track but rug up

Preparing for his 17th Ipswich Cup, track manager Sean Tou offered some valuable...

Council tears down serial litigant’s eye-catching signs

Premium Content Council tears down serial litigant’s eye-catching signs

Over the years his signs have targeted several high-profile politicians, police and...

New 5G phone tower planned to improve network

Premium Content New 5G phone tower planned to improve network

The telco is looking to improve its network across Ipswich with several...